Discover your next big idea for life sciences at PACK EXPO Las Vegas
Experience a breakthrough in life sciences packaging—explore solutions from 2,300 suppliers spanning all industries, all in one place this September

The People Have Spoken: Medicinal Marijuana > Prescription Drugs

Researchers at University of Michigan found that patients will likely use medical marijuana as a supplement or substitute for prescription drugs.

Marijuana vs Prescription Drugs / Image: U-M
Marijuana vs Prescription Drugs / Image: U-M

A recent article from University of Michigan’s Michigan News discussed a new study that examined the relationship between medical marijuana and pharmaceutical drugs. Medical cannabis is typically prescribed to treat pain, back issues, depression and headaches. Often times, it can be used as an alternative to prescription drugs that could come with a variety of side effects or dependency.

The researchers distributed 450 surveys to adults who use cannabis at a public event for marijuana law reform at U-M, where medical cannabis has been legal since 2008. Of the survey participants, 44% of medical marijuana users stopped taking a pharmaceutical drug or used less of one, or both, in favor of cannabis. 78% reported using marijuana to treat a medical or health condition, noting preference over pharmaceutical drugs due to higher ratings on effectiveness, side effects, availability, and cost.

List: Digitalization Companies From PACK EXPO
Looking for CPG-focused digital transformation solutions? Download our editor-curated list from PACK EXPO featuring top companies offering warehouse management, ERP, digital twin, and MES software with supply chain visibility and analytics capabilities—all tailored specifically for CPG operations.
Download Now
List: Digitalization Companies From PACK EXPO
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?